Literature DB >> 11328662

mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting.

K I Hosoya1, T Takashima, K Tetsuka, T Nagura, S Ohtsuki, H Takanaga, M Ueda, N Yanai, M Obinata, T Terasaki.   

Abstract

Brain capillary endothelial cell lines (TR-BBB) were established from a recently developed transgenic rat harboring temperature-sensitive simian virus 40 (ts SV 40) large T-antigen gene (Tg rat) and used to characterize the endothelial marker, transport activity, and mRNA expression of transporters and tight-junction strand proteins at the blood-brain barrier (BBB). These cell lines expressed active large T-antigen and grew well at 33 degrees C with a doubling-time of about 22-31 hr, but did not grow at 39 degrees C. TR-BBBs expressed the typical endothelial marker, von Willebrand factor, and exhibited acetylated low-density lipoprotein uptake activity. Although the gamma-glutamyltranspeptidase activity in TR-BBBs was approximately 13% of that of the brain capillary fraction of a normal rat, it was localized in the apical side, suggesting that it reflects the functional polarity of the in vivo BBB. The mRNA of tight-junction strand proteins such as claudine-5, occludin, and junctional adhesion molecule are expressed in TR-BBB13. Drug efflux transporter, P-glycoprotein, with a molecular weight of 170 kDa was expressed in all TR-BBBs and mdr 1a, mdr 1b, and mdr 2 mRNA were detected in TR-BBBs using RT-PCR. Moreover, mrp1 mRNA was expressed in all TR-BBBs. Influx transporter, GLUT-1, expressed at 55 kDa was revealed by Western blot analysis. It had 3-O-methyl-D-glucose (3-OMG) uptake activity which was concentration-dependent with a Michaelis-Menten constant of 9.86 +/- 1.20 mM. The mRNA of large neutral amino acid transporter, which consists of LAT-1 and 4F2hc was expressed in TR-BBBs. In conclusion, the conditionally immortalized rat brain capillary endothelial cell lines (TR-BBB) had endothelial makers, expressed mRNA for tight-junction strand proteins and the influx and efflux transporters and produced GLUT-1, which is capable of 3-OMG transport activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11328662     DOI: 10.3109/10611860008997912

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  13 in total

1.  Augmented expression of the tight junction protein occludin in brain endothelial cell line TR-BBB by rat angiopoietin-1 expressed in baculovirus-infected Sf plus insect cells.

Authors:  Himashi Iizasa; Sun-Hye Bae; Tomoko Asashima; Tomohide Kitano; Noriko Matsunaga; Tetsuya Terasaki; Young-Sook Kang; Emi Nakashima
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

Review 2.  Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.

Authors:  Tetsuya Terasaki; Sumio Ohtsuki
Journal:  NeuroRx       Date:  2005-01

Review 3.  Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions.

Authors:  Françoise Roux; Pierre-Olivier Couraud
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

4.  Homocysteine transport by human aortic endothelial cells: identification and properties of import systems.

Authors:  Beatrix Büdy; RoseMarie O'Neill; Patricia M DiBello; Shantanu Sengupta; Donald W Jacobsen
Journal:  Arch Biochem Biophys       Date:  2006-01-13       Impact factor: 4.013

5.  The acetylcholinesterase inhibitors competitively inhibited an acetyl L-carnitine transport through the blood-brain barrier.

Authors:  Na-Young Lee; Hyung-Ok Choi; Young-Sook Kang
Journal:  Neurochem Res       Date:  2012-02-23       Impact factor: 3.996

Review 6.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

7.  In Vivo and In Vitro Evidence for Brain Uptake of 4-Phenylbutyrate by the Monocarboxylate Transporter 1 (MCT1).

Authors:  Na-Young Lee; Young-Sook Kang
Journal:  Pharm Res       Date:  2016-03-29       Impact factor: 4.200

8.  The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells.

Authors:  Kaoru Yamada; Tadafumi Hashimoto; Chiori Yabuki; Yusuke Nagae; Masanori Tachikawa; Dudley K Strickland; Qiang Liu; Guojun Bu; Jacob M Basak; David M Holtzman; Sumio Ohtsuki; Tetsuya Terasaki; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

Review 9.  Neurovascular unit transport responses to ischemia and common coexisting conditions: smoking and diabetes.

Authors:  Ali E Sifat; Bhuvaneshwar Vaidya; Heidi Villalba; Thamer H Albekairi; Thomas J Abbruscato
Journal:  Am J Physiol Cell Physiol       Date:  2018-09-12       Impact factor: 4.249

10.  Differences in Cerebral Distribution between Imipramine and Paroxetine via Membrane Transporters at the Rat Blood-Brain Barrier.

Authors:  Shin-Ichi Akanuma; Myeongrae Han; Yuka Murayama; Yoshiyuki Kubo; Ken-Ichi Hosoya
Journal:  Pharm Res       Date:  2022-02-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.